The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy

Purpose: Triple-negative breast cancer (TNBC) is a subtype with distinct heterogeneity, high invasiveness, and poorer prognosis. There is a controversy about adjuvant chemotherapy (ACT) at the T1aN0M0 stage. This study was carried out to assess the survival benefit of ACT for these patients. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Wen-Fen, Chen, Qing-Xia, Wang, Xiao-Xiao, Zhang, Jie, Song, Chuan-Gui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556218/
https://www.ncbi.nlm.nih.gov/pubmed/33102205
http://dx.doi.org/10.3389/fonc.2020.01753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556218/
https://www.ncbi.nlm.nih.gov/pubmed/33102205
http://dx.doi.org/10.3389/fonc.2020.01753

Ejemplares similares